Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient

Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient

US Patent 10746726 · Granted Aug 18, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HMGN partial peptide and cancer therapy using the same2024
HMGN partial peptide and cancer therapy using the same2024
HMGN partial peptide and cancer therapy using the same2024
HMGN partial peptide and cancer therapy using the same2024
HMGN partial peptide and cancer therapy using the same2023
HMGN partial peptide and cancer therapy using the same2023
HMGN partial peptide and cancer therapy using the same2023
HMGN partial peptide and cancer therapy using the same2023
Method for predicting prognosis of patient with cancer or inflammatory disease2021
Method for reducing side effects of immune checkpoint control agent2021
Method for reducing side effects of immune checkpoint control agent2021
Method for reducing side effects of immune checkpoint control agent2021